Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.

Morris G, Anderson G, Maes M.

Mol Neurobiol. 2017 Nov;54(9):6806-6819. doi: 10.1007/s12035-016-0170-2. Epub 2016 Oct 20. Review.

PMID:
27766535
2.
4.

An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.

Maes M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):784-94. doi: 10.1016/j.pnpbp.2010.06.023. Epub 2010 Jul 4. Review.

PMID:
20609377
5.

A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Morris G, Maes M.

Metab Brain Dis. 2013 Dec;28(4):523-40. doi: 10.1007/s11011-012-9324-8. Epub 2012 Jun 21. Review.

PMID:
22718491
6.

Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?

Van Houdenhove B, Van Den Eede F, Luyten P.

Med Hypotheses. 2009 Jun;72(6):701-5. doi: 10.1016/j.mehy.2008.11.044. Epub 2009 Feb 23.

PMID:
19237251
9.
10.

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Morris G, Berk M, Galecki P, Maes M.

Mol Neurobiol. 2014 Apr;49(2):741-56. doi: 10.1007/s12035-013-8553-0. Epub 2013 Sep 26. Review.

PMID:
24068616
11.

Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.

Maes M.

Mod Trends Pharmacopsychiatry. 2013;28:162-74. doi: 10.1159/000343982. Epub 2013 Feb 27. Review.

PMID:
25224898
12.

Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

de Vega WC, Herrera S, Vernon SD, McGowan PO.

BMC Med Genomics. 2017 Feb 23;10(1):11. doi: 10.1186/s12920-017-0248-3.

13.

Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.

Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Sch├╝rmeyer TH, Ehlert U.

Psychoneuroendocrinology. 2005 Feb;30(2):188-98.

PMID:
15471616
15.
16.

Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats.

Surapaneni DK, Adapa SR, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S.

J Ethnopharmacol. 2012 Aug 30;143(1):91-9. doi: 10.1016/j.jep.2012.06.002. Epub 2012 Jul 6.

PMID:
22771318
17.

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome.

Anderson G, Berk M, Maes M.

Acta Psychiatr Scand. 2014 Feb;129(2):83-97. doi: 10.1111/acps.12182. Epub 2013 Aug 17. Review.

PMID:
23952563
18.

In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.

Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.

J Affect Disord. 2013 Sep 5;150(2):223-30. doi: 10.1016/j.jad.2013.03.029. Epub 2013 May 10.

PMID:
23664637
19.

Intracerebroventricular injection of leukotriene B4 attenuates antigen-induced asthmatic response via BLT1 receptor stimulating HPA-axis in sensitized rats.

Zhang SJ, Deng YM, Zhu YL, Dong XW, Jiang JX, Xie QM.

Respir Res. 2010 Apr 20;11:39. doi: 10.1186/1465-9921-11-39.

20.

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.

Maes M, Mihaylova I, Kubera M, Leunis JC, Twisk FN, Geffard M.

Metab Brain Dis. 2012 Dec;27(4):415-23. doi: 10.1007/s11011-012-9316-8. Epub 2012 May 22.

PMID:
22614823

Supplemental Content

Support Center